In PNAS this week: DNA regulation in islet cells, algorithm predicts regulatory element marks in various tissues, and more.
The study seeks to identify biomarkers that can help personalize treatment for patients by identifying signs of rapid decline in kidney function.
The collaborators plan to collect samples that will allow them insight into participants' microbiomes in order to understand disease mechanisms over time.
Danish researchers link the expression of three genes to being obese, but metabolically healthy, the Guardian reports.
In Nature this week: DNA methylation patters can uncover people at increased risk of diabetes, and more.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
By studying variants in PCSK9, researchers reported the therapies targeting the gene would have some of the same effects as statins.
The company plans to recruit one million patients from Mexico over three years and then expand to Columbia, Argentina, and Brazil.
The single-cell approach enabled them to identify gene expression in rare cell types, highlighting a previously unrecognized role for these cells in diabetes.
University of Cambridge researchers found that people who learned their genetic risk of developing diabetes did not have increased motivation to make lifestyle changes.
At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.
The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.
Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.
In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.